My research explores problems in health outcome and pharmacoepidemiology research, particularly with regards to comparative effectiveness and safety of drug products. The goal of my research is to provide effective strategies and interventions to improve population health and eliminate health disparities. My recent research involves in promoting generic drug post-marketing surveillance and education with collaboration from off campus partners supported by multiple U.S. FDA grants. Additional research interests include mental health and disability research, treatment optimization and outcomes for patients with multiple chronic conditions, medication adherence, quality of care among vulnerable populations.
